Close
  Indian J Med Microbiol
 

Figure 6: Hepatoprotective potential of Solanum nigrum. Rat of (a) normal control group; (b): Toxic control group; (c): Standard drug (Silymarin) group; (d) n- butanol fraction Solanum nigrum berries (25 mg/kg), (e) n- butanol fraction Solanum nigrum berries (16 mg/kg) and (f) crude extract of Solanum nigrum berries (250 mg/kg). CV: Central vein, PV: Portal vein, HA, N: Necrosis, H: Hepatocytes, MN: Mild necrosis, CS: Congestion in sinusoidal spaces, BD: Ballooning degeneration, CC: Congestion in central vein and S (sinusoids)

Figure 6: Hepatoprotective potential of <i>Solanum nigrum</i>. Rat of (a) normal control group; (b): Toxic control group; (c): Standard drug (Silymarin) group; (d) <i>n-</i> butanol fraction <i>Solanum nigrum</i> berries (25 mg/kg), (e) <i>n-</i> butanol fraction <i>Solanum nigrum</i> berries (16 mg/kg) and (f) crude extract of <i>Solanum nigrum</i> berries (250 mg/kg). CV: Central vein, PV: Portal vein, HA, N: Necrosis, H: Hepatocytes, MN: Mild necrosis, CS: Congestion in sinusoidal spaces, BD: Ballooning degeneration, CC: Congestion in central vein and S (sinusoids)